Basic Information
Invectys is an advanced clinical-stage biopharmaceutical company dedicated to developing innovative immunotherapies for the treatment of cancer. Invectys employs a novel approach to mobilize and restore the anti-tumor capabilities of the immune system in cancer patients.
Invectys Inc.
Paris,Ile-de-France,France
15~50 people
January 01, 2010
--